Global Medical Products Holdings, Inc., Order of Suspension of Trading, 22168-22169 [2010-9811]

Download as PDF 22168 Federal Register / Vol. 75, No. 80 / Tuesday, April 27, 2010 / Notices Incident Period: 03/12/2010 through 03/30/2010. Effective Date: 04/19/2010. Physical Loan Application Deadline Date: 06/18/2010. Economic Injury (EIDL) Loan Application Deadline Date: 01/19/2011. ADDRESSES: Submit completed loan applications to: U.S. Small Business Administration, Processing and Disbursement Center, 14925 Kingsport Road, Fort Worth, TX 76155. FOR FURTHER INFORMATION CONTACT: A. Escobar, Office of Disaster Assistance, U.S. Small Business Administration, 409 3rd Street, SW., Suite 6050, Washington, DC 20416. SUPPLEMENTARY INFORMATION: Notice is hereby given that as a result of the Administrator’s disaster declaration, applications for disaster loans may be filed at the address listed above or other locally announced locations. The following areas have been determined to be adversely affected by the disaster: Primary Counties: Suffolk. Contiguous Counties: New York: Nassau. The Interest Rates are: Percent SMALL BUSINESS ADMINISTRATION Region VI—Houston District; Advisory Council Meeting; Public Meeting The Small Business AdministrationRegion VI—Houston Advisory Council, located in the geographical Area of Houston, Texas will hold a federal public meeting on—Thursday, May 20, 2010, starting at 10:30 a.m. The meeting will be conducted in the Conference Room at the Small Business Administration, 8701 S. Gessner Drive, Suite 1200, Houston, TX 77074. The purpose of the meeting is to discuss the following. (1) Houston District Office Performance Goals for 2009–2010. (2) National SBA Initiatives. (3) Markets Perception And How To Increase SBA Lending. (4) Secondary Market. (5) Small Business Week Awards Luncheon. For further information, write to Alfreda Crawford, Business Development Specialist, at the Small Business Administration, 8701 S. Gessner, Suite 1200, Houston, TX 77074 or call (713) 773–6555. Dan Jones, White House Liaison/Committee Management Officer. [FR Doc. 2010–9713 Filed 4–26–10; 8:45 am] BILLING CODE 8025–01–P For Physical Damage: Homeowners With Credit Available Elsewhere ...................... Homeowners Without Credit Available Elsewhere .............. Businesses With Credit Available Elsewhere ...................... Businesses Without Credit Available Elsewhere .............. Non-Profit Organizations With Credit Available Elsewhere ... Non-Profit Organizations Without Credit Available Elsewhere ..................................... For Economic Injury: Businesses & Small Agricultural Cooperatives Without Credit Available Elsewhere .................. Non-Profit Organizations Without Credit Available Elsewhere ....... 5.250 2.625 6.000 4.000 3.625 3.000 3.000 mstockstill on DSKH9S0YB1PROD with NOTICES The number assigned to this disaster for physical damage is 12128 6 and for economic injury is 12129 0. The State which received an EIDL Declaration # is New York. (Catalog of Federal Domestic Assistance Numbers 59002 and 59008) Dated: April 19, 2010. Karen G. Mills, Administrator. [FR Doc. 2010–9711 Filed 4–26–10; 8:45 am] BILLING CODE 8025–01–P VerDate Nov<24>2008 16:09 Apr 26, 2010 Jkt 220001 By the Commission. Elizabeth M. Murphy, Secretary. [FR Doc. 2010–9810 Filed 4–23–10; 4:15 pm] SECURITIES AND EXCHANGE COMMISSION [File No. 500–1] ADSOUTH PARTNERS, Inc., American Racing Capital, Inc., Buck-A–Roo$ Holding Corporation, DDS Technologies USA, Inc., and VECTr Systems Inc.; Order of Suspension of Trading April 23, 2010. 4.000 lack of current and accurate information concerning the securities of Buck-A– Roo$ Holding Corporation (CIK: 1314642) because it has not filed a periodic report for any reporting period since the period ended March 31, 2008. It appears to the Securities and Exchange Commission that there is a lack of current and accurate information concerning the securities of DDS Technologies USA, Inc. (CIK: 1099217) because it has not filed a periodic report for any reporting period since the period ended September 30, 2006. It appears to the Securities and Exchange Commission that there is a lack of current and accurate information concerning the securities of VECTr Systems Inc. (CIK: 1343259) because it has not filed a periodic report for any reporting period since the period ended September 30, 2007. The Commission is of the opinion that the public interest and the protection of investors require a suspension of trading in the securities of the above-listed companies. Therefore, it is ordered, pursuant to section 12(k) of the Securities Exchange Act of 1934, that trading in the securities of the abovelisted companies is suspended for the period from 9:30 a.m. EDT on April 23, 2010, through 11:59 p.m. EDT on May 6, 2010. It appears to the Securities and Exchange Commission that there is a lack of current and accurate information concerning the securities of ADSOUTH PARTNERS, Inc. (CIK: 1158235) because it has not filed a periodic report for any reporting period since the period ended September 30, 2006. It appears to the Securities and Exchange Commission that there is a lack of current and accurate information concerning the securities of American Racing Capital, Inc. (CIK: 1103086) because it has not filed a periodic report for any reporting period since the period ended March 31, 2008. It appears to the Securities and Exchange Commission that there is a PO 00000 Frm 00074 Fmt 4703 Sfmt 4703 BILLING CODE 8011–01–P SECURITIES AND EXCHANGE COMMISSION [File No. 500–1] Global Medical Products Holdings, Inc., Order of Suspension of Trading April 23, 2010. It appears to the Securities and Exchange Commission that there is a lack of current and accurate information concerning the securities of Global Medical Products Holdings, Inc. because it has not filed any periodic reports since the period ended June 30, 2003. The Commission is of the opinion that the public interest and the protection of investors require a suspension of trading in the securities of the above-listed company. Therefore, it is ordered, pursuant to Section 12(k) of the Securities Exchange Act of 1934, that trading in the securities of the abovelisted company is suspended for the period from 9:30 a.m. EDT on April 23, 2010, through 11:59 p.m. EDT on May 6, 2010. E:\FR\FM\27APN1.SGM 27APN1 Federal Register / Vol. 75, No. 80 / Tuesday, April 27, 2010 / Notices By the Commission. Elizabeth M. Murphy, Secretary. [FR Doc. 2010–9811 Filed 4–23–10; 4:15 pm] BILLING CODE 8011–01–P SECURITIES AND EXCHANGE COMMISSION [Release No. 34–61953; File No. SR– NYSEArca–2010–07] Self-Regulatory Organizations; NYSE Arca, Inc.; Notice of Withdrawal of Proposed Rule Change Relating to Listing of AdvisorShares WCM/BNY Mellon Focused Growth ADR ETF April 21, 2010. On February 23, 2010, NYSE Arca, Inc. (‘‘NYSE Arca’’ or ‘‘Exchange’’), through its wholly owned subsidiary, NYSE Arca Equities, Inc. (‘‘NYSE Arca Equities’’), filed with the Securities and Exchange Commission (‘‘Commission’’), pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934 (‘‘Act’’) 1 and Rule 19b–4 thereunder,2 a proposed rule change to list and trade shares (‘‘Shares’’) of the AdvisorShares WCM/BNY Mellon Focused Growth ADR ETF (the ‘‘Fund’’) under NYSE Arca Equities Rule 8.600 (Managed Fund Shares). The proposed rule change was published in the Federal Register on March 10, 2010.3 No comments were received on the proposal. On April 9, 2010, the Exchange withdrew the proposed rule change. For the Commission, by the Division of Trading and Markets, pursuant to delegated authority.4 Florence E. Harmon, Deputy Secretary. [FR Doc. 2010–9677 Filed 4–26–10; 8:45 am] BILLING CODE 8011–01–P SECURITIES AND EXCHANGE COMMISSION [Release No. 34–61947; File No. SR–NYSE– 2010–18] mstockstill on DSKH9S0YB1PROD with NOTICES Self-Regulatory Organizations; New York Stock Exchange LLC; Order Approving Proposed Rule Change To Amend the Bylaws of NYSE Euronext To Adopt a Majority Voting Standard in Uncontested Elections of Directors April 20, 2010. On March 5, 2010, the New York Stock Exchange LLC (‘‘NYSE’’ or U.S.C. 78s(b)(1). CFR 240.19b–4. 3 See Securities Exchange Act Release No. 61642 (March 3, 2010), 75 FR 11216. 4 17 CFR 200.30–3(a)(12). ‘‘Exchange’’) filed with the Securities and Exchange Commission (‘‘Commission’’), pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934 (‘‘Act’’),1 and Rule 19b–4 thereunder,2 a proposed rule change to amend the By-Laws of its parent corporation, NYSE Euronext (‘‘Corporation’’). The proposed rule change was published for comment in the Federal Register on March 18, 2010.3 The Commission received no comment letters on the proposed rule change. This order approves the proposed rule change. On behalf of the Corporation, NYSE proposed to make certain amendments to the Corporation’s By-Laws to modify its direct election procedures. Under the existing By-Laws, directors are elected by a plurality of the votes of the shares present in person or represented by proxy at the meeting and entitled to vote on the election of directors. Under the Corporation’s corporate governance guidelines previously adopted by the Board, however, any director nominee in an uncontested election (being an election in which the number of nominees equals the number of directors to be elected) who receives a greater number of ‘‘withheld’’ votes than ‘‘for’’ votes (including any ‘‘against’’ votes if that option were to be made available on the proxy card) must immediately tender his or her resignation from the Board. NYSE proposed to amend the Corporation’s By-Laws to add an explicit majority voting provision for uncontested director elections that would replace the plurality vote standard for such elections that is currently in the By-Laws. Contested elections would remain subject to the plurality standard. Under the proposed amendment to the Bylaws, the proxy card would change for an uncontested election, and the stockholders would be given the choice to vote ‘‘for,’’ ‘‘against’’ or ‘‘abstain’’ with respect to each director nominee individually. In such an election, each director would be elected by the vote of the majority of the votes cast with respect to such director’s election, meaning that the number of votes cast ‘‘for’’ such director’s election exceeded the number of votes cast ‘‘against’’ that director’s election (with ‘‘abstentions’’ not counted as a vote either ‘‘for’’ or ‘‘against’’ such director’s election). If any incumbent director fails to receive a majority of the votes cast, 1 15 2 17 VerDate Nov<24>2008 16:09 Apr 26, 2010 Jkt 220001 1 15 U.S.C. 78s(b)(1). CFR 240.19b–4. 3 See Securities Exchange Act Release No. 61694 (March 11, 2010), 75 FR 13170. 2 17 PO 00000 Frm 00075 Fmt 4703 Sfmt 4703 22169 such director would be required to tender his or her resignation to the Nominating and Governance Committee of the Board (or another committee designated by the Board), and such committee would recommend to the Board whether to accept or reject such resignation or whether other action should be taken. The Board would then act on the recommendation of such committee and publicly disclose its decision regarding the tendered resignation and the rationale behind the decision.4 Pursuant to the proposed amendment to the By-Laws, if the Board accepts a director’s resignation as part of the process described above for uncontested elections, or if a nominee for director is not elected and the nominee is not an incumbent director, the Board may (i) fill the remaining vacancy as provided in Section 3.6 of the By-Laws and Article VI, Section 6 of the Certificate of Incorporation (involving a majority vote of the remaining directors then in office, though less than a quorum, or by the sole remaining director) or (ii) decrease the size of the Board as provided in Section 3.1 of the Bylaws and Article VI, Section 3 of the Certificate of Incorporation (involving adoption of a resolution by two-thirds of the directors then in office). After careful review, the Commission finds that the proposed rule change is consistent with the requirements of the Act and the rules and regulations thereunder applicable to a national securities exchange.5 In particular, the Commission finds that the proposed rule change is consistent with Section 6(b)(1) of the Act,6 which requires an exchange to be so organized and have the capacity to carry out the purposes of the Act and to comply and to enforce compliance by its members and persons associated with its members with the Act. The Commission also finds that the 4 The proposed amendment to the Bylaws also provides that a director who tenders his or her resignation would not participate in the recommendation by the Nominating and Governance Committee or the Board of Directors action regarding whether to accept the tendered resignation. If each member of the Nominating and Governance Committee fails to receive a majority of the votes cast in the same uncontested election, then the independent directors who received a majority of the votes cast in such election must appoint a committee among themselves to consider the tendered resignation and recommend to the Board whether to accept it. However, if the only directors who received a majority of the votes cast in such election constitute three or fewer directors, all directors may participate in the action regarding whether to accept the tendered resignation. 5 In approving this proposed rule change, the Commission notes that it has considered the proposed rule’s impact on efficiency, competition, and capital formation. See 15 U.S.C. 78c(f). 6 15 U.S.C. 78(b)(1). E:\FR\FM\27APN1.SGM 27APN1

Agencies

SECURITIES AND EXCHANGE COMMISSION

[Federal Register Volume 75, Number 80 (Tuesday, April 27, 2010)]
[Notices]
[Pages 22168-22169]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-9811]


-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[File No. 500-1]


Global Medical Products Holdings, Inc., Order of Suspension of 
Trading

April 23, 2010.
    It appears to the Securities and Exchange Commission that there is 
a lack of current and accurate information concerning the securities of 
Global Medical Products Holdings, Inc. because it has not filed any 
periodic reports since the period ended June 30, 2003.
    The Commission is of the opinion that the public interest and the 
protection of investors require a suspension of trading in the 
securities of the above-listed company. Therefore, it is ordered, 
pursuant to Section 12(k) of the Securities Exchange Act of 1934, that 
trading in the securities of the above-listed company is suspended for 
the period from 9:30 a.m. EDT on April 23, 2010, through 11:59 p.m. EDT 
on May 6, 2010.


[[Page 22169]]


    By the Commission.
Elizabeth M. Murphy,
Secretary.
[FR Doc. 2010-9811 Filed 4-23-10; 4:15 pm]
BILLING CODE 8011-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.